As for DVL‐1, which is highly expressed in various tumor types including breast cancer, it is targeted for suppression in cancer therapies because it regulates oncogenic Wnt signaling, an important driver of tumor progression [75]. This evidence concerns the gene DVL1 and neoplasm.